Rheumatoid Arthritis-API Insights, 2017 Scope:
Rheumatoid Arthritis-API Insights, 2017 Scope:
• A snapshot of the global Market therapeutics scenario for Rheumatoid Arthritis.
• A review of the marketed products under prescription for Rheumatoid Arthritis, regulatory information and marketing status.
• Coverage of global patent coverage and detailed commentaries on the US patent challenges.
• Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
• Product profiles for marketed products for Rheumatoid Arthritis with complete description of mechanism of action, therapeutic class, target, route( s) of administration and chemical details.
• Coverage of API Manufacturers for Rheumatoid Arthritis drugs in the United States, Europe and Asian Regions with location details.
• Coverage of Regulatory filings in the US, Europe, and Asia specifically India and China for Rheumatoid Arthritis drugs.
• Key discontinued Marketed products.
• Global Sales Figure from 2012-2016. Reasons to Buy
• Evaluate the marketing status and exclusivity details of Rheumatoid Arthritis key products to exploit opportunities for generic drug development opportunities.
• Key players in the pharmaceutical industry.
• Strategic drivers and restraints of this market are revealed and market opportunities and challenges are identified.
• Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Rheumatoid Arthritis.
• API intelligence over marketed drugs for Rheumatoid Arthritis and gaining primary intelligence over active ingredients manufacturers across the globe.